TradingView
RocketTickers
Dec 17, 2018 5:51 PM

Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR® L Long

NASDAQ:SUPN1D
Supernus Pharmaceuticals, Inc.NASDAQ

Description

⋅
SUPN: Supernus Pharmaceuticals, Inc.
2018-12-14 16:02:00
Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR® Label to Include Monotherapy
Beyond Technical Analysis
More